Can Tango Therapeutics (TNGX) Climb 37.28% to Reach the Level Wall Street Analysts Expect?

Group 1 - Tango Therapeutics, Inc. (TNGX) closed at $9.63, with a 22.4% gain over the past four weeks, and a mean price target of $13.22 suggests a 37.3% upside potential [1] - The mean estimate includes nine short-term price targets with a standard deviation of $1.39, indicating variability; the lowest estimate is $11.00 (14.2% increase), while the highest is $15.00 (55.8% increase) [2] - Analysts show strong agreement on TNGX's ability to report better earnings, with a positive trend in earnings estimate revisions, which is a strong indicator of potential upside [4][11] Group 2 - The Zacks Consensus Estimate for TNGX has increased by 2.3% due to one upward revision in the last 30 days, with no negative revisions [12] - TNGX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, indicating strong potential upside [13] - While consensus price targets may not be reliable for exact gains, they can provide a directional guide for price movement [14]